Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
BCPC 
Balchem Corporation (BCPC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/24/2025: BCPC (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
2 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $200.67
1 Year Target Price $200.67
| 0 | Strong Buy |
| 2 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -13.89% | Avg. Invested days 39 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/24/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 5.08B USD | Price to earnings Ratio 34.21 | 1Y Target Price 200.67 |
Price to earnings Ratio 34.21 | 1Y Target Price 200.67 | ||
Volume (30-day avg) 2 | Beta 0.92 | 52 Weeks Range 139.17 - 184.99 | Updated Date 10/25/2025 |
52 Weeks Range 139.17 - 184.99 | Updated Date 10/25/2025 | ||
Dividends yield (FY) 0.55% | Basic EPS (TTM) 4.58 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-10-24 | When - | Estimate 1.15 | Actual 1.35 |
Profitability
Profit Margin 14.72% | Operating Margin (TTM) 20.4% |
Management Effectiveness
Return on Assets (TTM) 7.87% | Return on Equity (TTM) 12.06% |
Valuation
Trailing PE 34.21 | Forward PE 29.24 | Enterprise Value 4889146528 | Price to Sales(TTM) 5.01 |
Enterprise Value 4889146528 | Price to Sales(TTM) 5.01 | ||
Enterprise Value to Revenue 4.96 | Enterprise Value to EBITDA 20.19 | Shares Outstanding 32386260 | Shares Floating 32214289 |
Shares Outstanding 32386260 | Shares Floating 32214289 | ||
Percent Insiders 0.37 | Percent Institutions 91.77 |
Upturn AI SWOT
Balchem Corporation
Company Overview
History and Background
Balchem Corporation was founded in 1967. Initially focused on encapsulation technology, it has evolved into a global specialty ingredients company, expanding through acquisitions and organic growth.
Core Business Areas
- Human Nutrition & Health: Develops, manufactures, and markets products for nutrition and health including chelated minerals, choline salts, and methylsulfonylmethane (MSM).
- Animal Nutrition & Health: Provides nutritional solutions for livestock, poultry, and companion animals, focusing on improving animal health and performance with products like rumen-protected nutrients.
- Specialty Products: Offers performance-enhancing products for industrial applications, including ethylene oxide, propylene oxide, and specialty packaging.
Leadership and Structure
Ted Harris is the Chairman, President, and CEO. The company operates with a functional organizational structure across its business segments, with centralized support functions.
Top Products and Market Share
Key Offerings
- REBAUDIOSIDE M (Reb M): A natural, high-intensity sweetener used in food and beverage applications. Market share data is not readily available, but competitors include Cargill (Eversweet), Ingredion (Bestevia), and Tate & Lyle (Dolcia Prima).
- REACh Choline: Choline products used in dietary supplements and infant formula. Market share data is unavailable. Competitors include companies that manufacture choline bitartrate and choline chloride.
- Niacin and Nicotinamide products: These are widely used forms of Vitamin B3. Market share data is not readily available.
Market Dynamics
Industry Overview
The specialty ingredients market is driven by consumer trends towards healthier and more sustainable products, with increasing demand for natural and functional ingredients. Animal nutrition is growing with a focus on improved animal welfare and productivity.
Positioning
Balchem is positioned as a leader in encapsulation and chelation technologies, offering differentiated products with strong scientific backing. The company's competitive advantages lie in its innovative product portfolio and strong customer relationships.
Total Addressable Market (TAM)
The TAM for Balchem's markets is estimated to be in the billions of dollars. Balchem is positioned well within this TAM, focusing on high-growth segments with differentiated products and specialized solutions.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Innovative product portfolio
- Leading market position in key segments
- Experienced management team
- Proprietary Encapsulation and Chelation Technologies
Weaknesses
- Dependence on key suppliers
- Vulnerability to raw material price fluctuations
- Limited geographic diversification in some segments
- Customer concentration in certain markets
Opportunities
- Expanding into new geographic markets
- Developing new applications for existing technologies
- Acquiring complementary businesses
- Capitalizing on growing demand for natural and sustainable ingredients
Threats
- Increased competition from larger players
- Changing regulatory landscape
- Economic downturns impacting consumer spending
- Fluctuations in raw material prices
Competitors and Market Share
Key Competitors
- ADM
- IFF
- DSM
Competitive Landscape
Balchem's advantages include its specialized technologies and strong customer relationships. Disadvantages may include its smaller size compared to larger competitors like ADM and IFF.
Major Acquisitions
Zinpro Performance Minerals
- Year: 2018
- Acquisition Price (USD millions): 420
- Strategic Rationale: Expanded Balchem's animal nutrition portfolio and global reach.
Growth Trajectory and Initiatives
Historical Growth: Balchem has demonstrated consistent growth over the past several years, driven by acquisitions and organic expansion in its core business segments.
Future Projections: Analyst estimates suggest continued growth for Balchem, driven by increasing demand for its specialty ingredients and strategic acquisitions.
Recent Initiatives: Recent initiatives include expanding production capacity, launching new products, and pursuing strategic acquisitions to enhance its product portfolio.
Summary
Balchem Corporation is a relatively strong company with a leadership position in specialty ingredients and animal nutrition, underpinned by its proprietary technologies. Its growth is driven by a strategic mix of organic expansion and targeted acquisitions, strengthening its market presence. Balchem needs to watch out for competition from larger players, and raw material cost volatility to maintain its profitability. Focusing on geographic diversification will enhance long term growth.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
Disclaimers:
This analysis is based on available information and does not constitute financial advice. Market conditions and company performance are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Balchem Corporation
Exchange NASDAQ | Headquaters Montvale, NJ, United States | ||
IPO Launch date 1986-06-03 | CEO, President & Chairman Mr. Theodore Lee Harris | ||
Sector Basic Materials | Industry Specialty Chemicals | Full time employees 1355 | Website https://www.balchem.com |
Full time employees 1355 | Website https://www.balchem.com | ||
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.